Seer (SEER) EBITDA Margin Growth (3y) (2023 - 2026)
Seer (SEER) EBITDA Margin Growth (3y) (2023 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
EBITDA Margin Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
719,706.53 Bn |
719,706.50 Bn |
- |
- |
| 2 |
Belite Bio |
55,800.00 Bn |
55,800.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
18,182.30 Bn |
18,182.29 Bn |
- |
- |
| 4 |
Legend Biotech |
3,154.00 Bn |
3,153.71 Bn |
242.10 Mn |
-40,178.00 |
| 5 |
Akari Therapeutics |
1,844.30 Bn |
1,844.29 Bn |
- |
- |
| 6 |
Evaxion A |
1,567.96 Bn |
1,567.94 Bn |
- |
- |
| 7 |
Psyence Biomedical |
251.43 Bn |
251.42 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
112.56 Bn |
105.31 Bn |
2.59 Bn |
530.00 |
| 9 |
Abivax |
94.37 Bn |
94.37 Bn |
- |
- |
| 10 |
Seer |
99.67 Mn |
99.67 Mn |
982,000.00 |
-5,898.00 |
| Date | Value |
|---|
| Mar 31, 2026 |
-5,898.00 |
| Dec 31, 2025 |
7,778.00 |
| Sep 30, 2025 |
15,625.00 |
| Jun 30, 2025 |
17,511.00 |
| Mar 31, 2025 |
29,464.00 |
| Dec 31, 2024 |
10,115.00 |
| Sep 30, 2024 |
35,805.00 |
| Jun 30, 2024 |
50,299.00 |
| Mar 31, 2024 |
2.59 Mn |
| Dec 31, 2023 |
350,031.00 |
| Sep 30, 2023 |
1.11 Mn |
| Jun 30, 2023 |
835,414.00 |
| Mar 31, 2023 |
223,969.00 |
